Dr. Rozakis
Medical Director and Founder in Lakewood, Ohio
Dr. Rozakis's current focus is to improve the standard of care for macular degeneration using a method that enhances cellular physiology. We seek to deliver this care through eye doctors to their patients using a telemedicine platform we developed. Our most recent news is the publication of a study in 365 Eyes where we found that we can improve vision in dry AMD and reduce the need for injections in wet AMD. We hope to be a resource for those interested in going beyond the current paradigm for AMD and other conditions caused by cellular dysfunction, of which there are many.